Terms: = Thyroid cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Staging
26 results:
1. Social Vulnerability Association with thyroid cancer Disparities in the United States.
Fei-Zhang DJ; Verma R; Arimoto R; Lawrence AS; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
Thyroid; 2024 Feb; 34(2):225-233. PubMed ID: 38069566
[No Abstract] [Full Text] [Related]
2. [Value of Baseline Calcitonin for Differential Diagnosis of Medullary thyroid cancer].
Liu QH; Nie X; He Y; Yin MT; Li GX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):432-438. PubMed ID: 36949711
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of Social Vulnerability in Pediatric Head and Neck cancer Care and Prognosis in the United States.
Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic Utility of Tumor Stage versus American thyroid Association Risk Class in thyroid cancer.
Abiri A; Pang J; Prasad KR; Goshtasbi K; Kuan EC; Armstrong WB; Haidar YM; Tjoa T
Laryngoscope; 2023 Jan; 133(1):205-211. PubMed ID: 35716358
[TBL] [Abstract] [Full Text] [Related]
5. [Multicenter real-world study on safety and efficacy of neoadjuvant therapy in combination with immunotherapy for colorectal cancer].
Liu XZ; Xiong Z; Xiao BY; Yu GY; Li YJ; Yao YF; Tao KX; Ding PR; Zhang W; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):219-227. PubMed ID: 35340171
[No Abstract] [Full Text] [Related]
6. Pan-cancer analysis of prognostic metastatic phenotypes.
Zaorsky NG; Wang X; Garrett SM; Lehrer EJ; Lin C; DeGraff DJ; Spratt DE; Trifiletti DM; Kishan AU; Showalter TN; Park HS; Yang JT; Chinchilli VM; Wang M
Int J Cancer; 2022 Jan; 150(1):132-141. PubMed ID: 34287840
[TBL] [Abstract] [Full Text] [Related]
7. Accuracy of the Lymph Node Yield in Surgery for Papillary thyroid cancer in Children.
Yap A; Shui A; Gosnell J; Huang CY; Sosa JA; Roman S
World J Surg; 2021 Oct; 45(10):3092-3098. PubMed ID: 34180009
[TBL] [Abstract] [Full Text] [Related]
8. Beyond Premature Ovarian Insufficiency: staging Reproductive Aging in Adolescent and Young Adult cancer Survivors.
Medica ACO; Whitcomb BW; Shliakhsitsava K; Dietz AC; Pinson K; Lam C; Romero SAD; Sluss P; Sammel MD; Su HI
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1002-e1013. PubMed ID: 33141175
[TBL] [Abstract] [Full Text] [Related]
9. Changes in Stage Distribution and Disease-Specific Survival in Differentiated thyroid cancer with Transition to American Joint Committee on cancer 8th Edition: A Systematic Review and Meta-Analysis.
Lechner MG; Bernardo AC; Lampe A; Praw SS; Tam SH; Angell TE
Oncologist; 2021 Feb; 26(2):e251-e260. PubMed ID: 32864832
[TBL] [Abstract] [Full Text] [Related]
10. Increasing incidence of cancer and stage migration towards advanced disease in children and young adolescents in the Netherlands, 1990-2017.
Reedijk AMJ; Kremer LC; Visser O; Lemmens V; Pieters R; Coebergh JWW; Karim-Kos HE
Eur J Cancer; 2020 Jul; 134():115-126. PubMed ID: 32521425
[TBL] [Abstract] [Full Text] [Related]
11. The
Yin N; Sherman SI; Pak Y; Litofsky DR; Gianoukakis AG;
Thyroid; 2020 Oct; 30(10):1490-1495. PubMed ID: 32228151
[No Abstract] [Full Text] [Related]
12. Stage II Differentiated thyroid cancer Is a High-Risk Disease in Patients <45/55 Years Old.
Liu Z; Shen X; Liu R; Zhu G; Huang T; Xing M
J Clin Endocrinol Metab; 2019 Nov; 104(11):4941-4948. PubMed ID: 31116377
[TBL] [Abstract] [Full Text] [Related]
13. T1a Versus T1b Differentiated thyroid cancers: Do We Need to Make the Distinction?
Anderson KL; Youngwirth LM; Scheri RP; Stang MT; Roman SA; Sosa JA
Thyroid; 2016 Aug; 26(8):1046-52. PubMed ID: 27266722
[TBL] [Abstract] [Full Text] [Related]
14. The Clinical Relevance of Psammoma Body and Hashimoto thyroiditis in Papillary thyroid Carcinoma: A Large Case-control Study.
Cai YF; Wang QX; Ni CJ; Guo GL; Li Q; Wang OC; Wu L; Du HY; You J; Zhang XH
Medicine (Baltimore); 2015 Nov; 94(44):e1881. PubMed ID: 26554782
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of microscopic lymph node involvement in patients with papillary thyroid cancer.
Bardet S; Ciappuccini R; Quak E; Rame JP; Blanchard D; de Raucourt D; Babin E; Michels JJ; Vaur D; Heutte N
J Clin Endocrinol Metab; 2015 Jan; 100(1):132-40. PubMed ID: 25303481
[TBL] [Abstract] [Full Text] [Related]
16. Increasing incidence of thyroid cancer in the Commonwealth of Pennsylvania.
Bann DV; Goyal N; Camacho F; Goldenberg D
JAMA Otolaryngol Head Neck Surg; 2014 Dec; 140(12):1149-56. PubMed ID: 25170647
[TBL] [Abstract] [Full Text] [Related]
17. The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.
Weinlander E; Somnay Y; Harrison AD; Wang C; Cheng YQ; Jaskula-Sztul R; Yu XM; Chen H
J Surg Res; 2014 Jul; 190(1):191-7. PubMed ID: 24679699
[TBL] [Abstract] [Full Text] [Related]
18. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer.
Esfandiari NH; Hughes DT; Yin H; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2014 Feb; 99(2):448-54. PubMed ID: 24276457
[TBL] [Abstract] [Full Text] [Related]
19. Validity of 6(th) edition of UICC TNM classification system for medullary thyroid carcinoma: a proposal for intraoperative evaluation of T category.
Ito Y; Kihara M; Hirokawa M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(5):407-16. PubMed ID: 22382509
[TBL] [Abstract] [Full Text] [Related]
20. thyroid cancer incidence among active duty U.S. military personnel, 1990-2004.
Enewold LR; Zhou J; Devesa SS; Berrington de Gonzalez A; Anderson WF; Zahm SH; Stojadinovic A; Peoples GE; Marrogi AJ; Potter JF; McGlynn KA; Zhu K
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2369-76. PubMed ID: 21914838
[TBL] [Abstract] [Full Text] [Related]
[Next]
